secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001178913-25-003309
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics prices $6.0M public offering of shares and warrants
-------------------------------------------------------------------------

- Raised $6.0M gross ($5.2M net) from sale of 1.5M share equivalents and warrants at $4.00/unit.
- Offering includes Series A (5-year) and Series B (12-month) warrants, each exercisable at $4.00/share.
- Placement agent H.C. Wainwright receives 7% cash fee plus 105,000 placement agent warrants at $5.00.
- Net proceeds to fund pre-clinical studies and general corporate purposes.
- Offering closed on Sept 12, 2025; securities registered under Form S-1 effective Sept 11.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/0001178913-25-003309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/zk2533780.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-003309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer